Extremely vulnerable in UK given top priority for coronavirus vaccine | World news



[ad_1]

People at very high risk of contracting the coronavirus due to health problems, which were made to protect during the pandemic, were given the same priority as over 70 to receive a Covid-19 vaccine.

People aged 18 and over who are considered “clinically extremely vulnerable” belong to the same priority group as those aged 70 and over, according to the provisional vaccine priority list published by Public Health England.

It means that people with conditions such as cancer of the blood, bone or lungs, chronic kidney disease, and Down syndrome were placed in the four out of nine priority group.

The updated list, which is subject to the Medicines and Health Products Regulatory Agency (MHRA) approving a vaccine supply, also lists conditions that fall into priority group six for at-risk adults aged 18 and 65 years.

These include people diagnosed with diabetes, chronic heart disease, and morbid obesity.

The provisional guide, recommended by the Joint Committee on Vaccination and Immunization (JCVI), states that the order of priority should be: elderly in nursing homes and home assistants; people in their eighties and health and social workers; those 75 years and beyond; those people aged 70 and over who are clinically extremely vulnerable, excluding pregnant women and people under 18

Everyone over 65, adults 18 to 65 in an at-risk group, those 60 and older, 55 and older, and people 50 and older make up the rest of the list.

graphic

Gemma Peters, Chief Executive Officer of the Blood Cancer UK charity, said: “This is extremely positive news. Putting people with blood cancer on the same priority level as those over the age of 70 better reflects the fact that they are particularly vulnerable to the coronavirus. “

Peters added: “Any vaccine may not work as well in people with blood cancer, so vaccinating the people around them is a vital part of protecting them. We are very grateful to the government for hearing the voices of people with blood cancer and other health conditions about this.

“It is also important to remember that this is definitely not the final priority list. No vaccines have been approved yet and we are awaiting confirmation that any vaccine will be safe and effective for people with blood cancer. “

The Pfizer / BioNTech vaccine was the first to submit its data for review by the MHRA last week.

Health Secretary Matt Hancock said there will be 10 million doses available in the UK by the end of the year out of the 40 million he has ordered.

Meanwhile, hospitals have been told to prepare for the launch of a coronavirus blast in just 10 days, with NHS workers expected to be in the front row, the Guardian learned. Problems with the transport and storage of the vaccine, which must be kept in cold temperatures, means that it cannot be easily transported by healthcare personnel such as GPs to nursing homes and private residences of the elderly to administer the vaccine to them earlier.

.

[ad_2]
Source link